Organization
Osaka Medical and Pharmaceutical University
1 abstract
Abstract
Phase II neoadjuvant trial of albumin-bound paclitaxel, trastuzumab and pertuzumab followed by anthracycline based regimens in patients with operable HER2 positive breast cancer (OMC-BC05).Org: Department of Breast Surgery Osaka Medical and Pharma ceutical University, Osaka Medical and Pharmaceutical University, Department of Rehabilitation Medicine Osaka Medical College, Osaka Medical snd Pharmaceutical University, Osaka Police Hospital,